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Abstract
Background: Helicobacter pylori, a widespread infection particularly in developing countries has been associated
with many adverse effects during pregnancy including hyperemesis gravidarum, neural tube defects in newborns,
intrauterine fetal growth restriction and miscarriage. We sought to document the effects of H. pylori infection on
birth weight in a low-income setting in Kampala, Uganda.
Methods: This was a prospective cohort study conducted in Kampala between May 2012 and May 2013. The
participants were H. pylori positive and H. pylori negative HIV negative primigravidae and secundigravidae.
Recruitment was at ≤18 gestation weeks and follow up assessments were carried out at 26 and 36 gestation
weeks and soon after delivery. H. pylori infection was determined using H. pylori stool antigen test. Maternal
weight and height were measured, and body mass index (BMI) and gestational weight gain were calculated.
Only term and live babies were considered. Low birth weight (LBW) was defined as a birth weight of <2500 gram.
Results: A total of 221 participants were enrolled with mean ± standard deviation (SD) age of 20.9 ± 2.7 years.
The mean ± SD gestation age at delivery was 39.4 ± 1.0 weeks. Primigravidae were 61.5 % (n = 188) and 52.9 %
(n = 117) of the participants were positive for H. pylori infection. Low pre-pregnancy BMI (<18.5 kg/m2) was
recorded in 14.6 % (n = 28) while 38 % (n = 73) had a height <156 cm at recruitment. Of the infants born to the
participants, 13.6 % (n = 26) had low birth weight (<2500 gram).
Independent predictors for LBW were the mother being positive for H. pylori infection (odds ratio, OR, 3.6, 95 %
CI 1.1 – 11.5; P = 0.031) maternal height at recruitment <156 cm (OR 3.4, 95 % CI 1.4–8.2; P = 0.008) and maternal
weight gain rates <0.3 kg/week during the 2nd and 3rd trimesters (OR 3.8, 95 % CI 1.0–14.1; P = 0.044).
Conclusion: H. pylori infection is associated with LBW among primigravidae and secundigravidae in Kampala, Uganda.
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Background
Helicobacter pylori (H. pylori) infection is the most com-
mon bacterial infection worldwide. Almost half of people
in developed countries and three-quarters of people in
developing countries are infected with H. pylori [1, 2].
Although many infected individuals are asymptomatic,
H. pylori is an important health problem. H. pylori infec-
tion has been recognized as a major cause of various
gastroduodenal diseases, such as chronic gastritis, peptic
ulcer disease, and gastric cancer [3]. In Uganda the
prevalence was 74 % in patients with dyspepsia referred
for endoscopy and 86 % in patients with cancer and be-
nign tumors [4, 5].
A high prevalence of H. pylori has been observed among
pregnant women. In Uganda, Baingana et al. recently
found 60 % prevalence of H. pylori infection among preg-
nant women [6]. Studies in Sudan, Mexico and Chile
found prevalence rate of 69.8 %, 52.2 % and 68.6 % in re-
spectively [7–9]. H. pylori infection in pregnancy is associ-
ated with many adverse effects, such as extreme, persistent
nausea and vomiting (hyperemesis gravidarum) [8, 10],
neural tube defects in newborns, pre-eclampsia with
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intrauterine fetal growth restriction and miscarriage, and
thrombocytopenia [11–14]. Furthermore, pregnant women
infected with H. pylori infection are at increased risk of
anemia [15, 16].
Pregnancy is a physiological condition in which a marked
increase in body weight occurs over a short period. An
optimum weight gain over the course of pregnancy, as rec-
ommended by the Institute of Medicine (IOM, 2009), is
one that produces a healthy newborn. Optimum weight
gain also provides sufficient postpartum maternal fat stores
to support lactation without increasing obesity risk [17].
Gestational weight gains below the IOM recommendation
are common in developing countries [18]. There is evi-
dence to show that maternal pre-pregnancy weight and
the weight gained during pregnancy influence birth
weight [19]. Inadequate gestational weight gain in-
creases the risk of preterm delivery and low birth
weight (LBW) infants [20, 21].
Birth weight is an important determinant of an infant’s
well-being. Infants born with LBW are at increased risk
of morbidity and mortality from infectious disease, and
suffer underweight, stunting or wasting beginning in the
neonatal period through childhood [22]. There is evi-
dence that adults born with LBW face an increased risk
of chronic diseases including high blood pressure, type
II diabetes mellitus, coronary heart disease and stroke in
adulthood [23]. In Uganda, the prevalence of LBW, at
10.5 %, is high [24].
An association between H. pylori and LBW has been
suggested [13, 14]. However, there is limited data on as-
sociation between H. pylori and birth weight especially
in developing countries. The objective of this study was
to establish the association between H. pylori infection
and birth weight.
Methods
Study design and site
This was a prospective cohort study in which pregnant
women were followed from the time of recruitment up to
delivery between May 2012 and May 2013. The study was
conducted at the antenatal clinic of Kawempe Health
Centre IV. The Health Centre is supported by the Minis-
try of Health, Uganda and the services in the antenatal
clinic are free to the public. This clinic serves a densely-
populated, low-income area in Kawempe, one of the five
Divisions forming Kampala District in Uganda. The Div-
ision is located in the Northern part of Kampala District.
Study population
Pregnant women attending antenatal at Kawempe Health
Centre constituted the study population. The target popula-
tion was HIV negative primigravidae and secundigravidae.
Sample size
We used online openEpi software, http://www.openepi.-
com, based on Kelsey Lesley (1996) to calculate sample
size. In the formula we used a confidence level of 95 %,
power of 80 %, ratio of H. pylori positive to H. pylori nega-
tive of one. Furthermore, in the formula we used 18 and
35 as the percentages of unexposed and exposed partici-
pants with outcome of interest according to Eslick [14].
The sample was divided two groups (exposed and unex-
posed). The exposed group (141) comprised of those who
tested positive for H. pylori infection while the unexposed
group (90) comprised who tested negative for H. pylori in-
fection. We anticipated 5 % lost to follow up.
Recruitment and follow up
A consecutive sampling procedure was used to select
participants who met the selection criteria until the sam-
ple size was achieved. The participants were chosen as
they got registered at the antenatal clinic. Written con-
sent for each eligible participant was sought after clear
information being given about the study objectives, pro-
cedures and benefits. In Uganda HIV testing for preg-
nant women is mandatory and is always done on the day
of the first visit antenatal clinic. The study participants
were recruited as informed volunteers at 12–18 weeks of
gestation based on the reported last menstrual period
and the experienced midwife’s examination. Follow up
assessments were carried at 26 and 36 weeks of gesta-
tion. This study only considered term neonates, that is,
babies who were delivered after 37 weeks of gestation.
The study participants were included in our cohort
based on the following criteria; between 18–35 years of
age, pregnant for the first or second time, HIV negative,
carrying singleton pregnancy, free of any systemic illness
such as hypertension, active peptic ulcers, diabetes melli-
tus or genetic abnormality, for example, sickle cell disease,
between gestation weeks 12–18 at the time of recruitment.
However, some of the pregnant women were excluded
from this study based on the following criteria; not able to
recall their pre-pregnancy weight, not able to schedule
their return visits, not able to speak and/or hear, mentally
ill, history of drug or alcohol abuse Based on the set exclu-
sion criteria, a total of 56 women excluded from this
study. Fourteen of them could not adhere to the scheduled
return visits, 2 were sickle cell patients, 4 were alcohol
abusers, 28 could not recall their pre-pregnancy weight, 6
had active peptic ulcers and 2 were carrying twins.
Data collection and determination of nutritional status
During participant’s interview, demographic data includ-
ing social, behavioral and medical history were collected
in structured questionnaires. Nutritional status of each
participant was assessed using anthropometric parame-
ters. Anthropometric measurements were carried out in
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a closed room when the participant was barefoot and
wearing light clothing. Body weight was measured using an
adult a portable beam scale with 150 kg capacity divided
into 0.5 kg increments (Gmbh & co.kg, Germany model
7621019009). Height was determined with the individual
barefoot and in an orthostatic position with the aid of a
portable stadiometer consisting of a non-extendable 2 meter
measuring tape divided into 0.1 cm increments. Body
weight and height were measured twice for every participant
and the average of the readings was considered as the par-
ticipant’s weight and height respectively. Each participant’s
BMI was calculated using the following formula: BMI =
body weight (kg) divided by [height (m)]2. The BMI was cat-
egorized as follows; underweight (<18.5 kg/m2), normal
weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2),
obese (≥30.0 kg/m2) [25]. The nutritional status of infants
was assessed from the birth weight measurements. Birth
weight was measured by baby weight scale (Fazzini) within
24 h after birth. A neonate was considered LBW if it
weighed less than 2500 grams.
Stool collection and testing for H. Pylori infection
After clear instructions on how to collect stool, each par-
ticipant was given clean tissue paper on which to deposit
the stool. After, she had to immediately transfer a stool
sample into stool collection bottle using the scooper which
was part of the bottle top. This was done in the antenatal
clinic toilet. Stool samples were immediately placed in a
cool box with ice packs. The samples were transported
everyday from Kawempe Health Centre to the laboratory
(~3 km) and stored in a −20 ° C freezer until analysis was
carried out. H. pylori stool antigen test, i-Chek cassettes
(Chem-Labs Limited, Nairobi, Kenya) were used to analyze
the stool samples. It is a rapid one-step chromatographic
immunoassay that utilizes a combination of anti-H. pylori
antibodies and anti-mouse IgG. Instructions given by the
manufacturer were followed. Approximately 100 μl of stool
of completely thawed stool was brought into the sample
diluent tube and vortexed for fifteen seconds. Three drops
of the diluted sample were applied to the test and the re-
sult was read after fifteen minutes. The results were
reported as positive or negative on the basis of the
manufacturer’s guidelines. A procedural control was
included with each test.
Data analysis
Data were analyzed using Statistical Package for Social Sci-
ences (SPSS) V.16.0 (SPSS Inc., Chicago, IL, USA). Social,
demographic and measurement parameters were summa-
rized into frequencies and mean ± standard deviation (SD).
The outcome variable was birth weight while the predictor
variables were H. pylori infection, rates of gestation weight
gains pre-pregnancy weight, pre-pregnancy BMI, parity
and maternal height. Continuous data were checked for
normality. Tests for the significance of association were
made using the Pearson chi-square (χ2) test for categorical
variables and independent sample t test for continuous var-
iables. Factors associated with birth weight were deter-
mined with logistic regression. Factors associated with
birth weight with P values <0.05 during univariate analysis
were considered for multivariate analysis using logistic re-
gression to determine factors independently associated
with birth weight. Odds ratio (OR) and 95 % confidence
interval (CI) were reported. At multivariate analysis, statis-
tical significance was determined if p < 0.05.
Results
Table 1 summarizes the overall socio-demographic char-
acteristics of the study participants. Two hundred 221
HIV-negative pregnant women were enrolled into the
study. 26 of the 221 were lost to follow up and of 26, 20
were negative for H. pylori infection. All the 221 en-
rolled were used to calculate the prevalence of H. pylori
infection among the participants. The prevalence H. pyl-
ori infection was 52.9 % (117/221). However, data from
only 192 participants was used to perform all the other
analyses because two of the participants lost their preg-
nancies at 22 and 25 weeks of gestation, one delivered
before 37 weeks of gestation. Birth weight of one baby
born to a participant who completed the study was not
captured as it was still birth. 61.5 % (188/192) of the par-
ticipants were pregnant for the first time. 87.5 % (168/
192) of the participants were married, 9.9 % (19/192)
were single and the rest were either divorced/separated or
widowed. Only 1.0 % (2/192) and 5.2 % (10/192) were
smokers and were taking alcohol respectively. The major-
ity, 64.6 % (124/192), of the participants had acquired sec-
ondary education. The majority of the participants 78.1 %
(144/192) were housewives and only 19.8 % (38/192) were
employed. Underweight (BMI <18.5 kg/m2) was recorded
in 14.6 % (28/192) of the participants. 38.0 % (73/192) of
the participants had height <156 cm and 65.6 % (126/192)
were less than 21 years of age. Of the infants born to par-
ticipants, 52.6 % (101/192) were females and 13.6 % (26/
191) had low birth weight (<2500 g). From Tables 1 and 2,
we observe that there were no differences in the socio-
demographic variables between the participants with H.
Pylori infection and those without H. Pylori infection ex-
cept for LBW (P = 0.002).
Table 3 shows the means ± standard deviations (SD) and
ranges for the selected variables and the difference be-
tween H. pylori positive and H. pylori negative participants.
The participants had a mean ± SD (kg/week) rate of weight
gain of 0.30 ± 0.11 with a range of 0.08–0.75 and there was
a difference in the rates of weight gain between H. pylori
positive and H. pylori negative participants (P < 0.001).
The mean ± SD gestation age at delivery was 39.4 ± 1.0
with a range of 37 – 42 weeks. There was no difference in
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mean gestation age at delivery between H. pylori positive
and H. pylori negative participants (P = 0.494). The mean ±
SD birth weight was 2922 ± 476 g with a range of 1700–
4400 g and the mean birth weight of babies born to H. pyl-
ori positive mothers was significantly different from that
of babies born to H. pylori negative participants (P <
0.001). The mean ± SD (range) pre-pregnancy weight,
pre-pregnancy BMI and maternal height were 53.1 ±
7.7 kg (37–76 kg), 21.5 ± 2.7 kg/m2 (15.0–29.4 kg/m2)
and 157.4 ± 5.8 cm (142.0–173.1 cm) respectively. The
mean pre-pregnancy weight, pre-pregnancy BMI and
maternal height of H. pylori positive participants were
not significantly different from those of H. pylori nega-
tive participants.
Factors associated with low birth weight
For logistic regression, low birth weight (BW <2500 grams)
was used as the outcome variable. The covariates were H.
pylori status, maternal gestation rate of weight gain, mater-
nal height, and parity (Table 4). However, the independent
predictors for LBW were the mother being positive for
H. pylori infection (odds ratio, OR, 3.6, 95 % CI 1.1–
11.5; P = 0.031), maternal height at recruitment <156 cm
(OR 3.4, 95 % CI 1.4–8.2; P = 0.008) and maternal
Table 1 Comparison of categorical socio-demographic
characteristics by H. pylori status











Widowed/Divorced 4 1 0.445*
Maternal pre-pregnancy
BMI (kg/m2)
Underweight (<18.5) 15 13
Normal weight (18.5–24.9) 80 63
Overweight (25.0–29.9) 15 6 0.372*
Sex of the baby
Female 56 44
Male 54 38 0.706
Birth weight (grams)a
<2500 22 4




≥156 68 51 0.958*
Maternal age (years)
<21 70 56





Student 7 2 0.561*
Smoking
Yes 0 2
No 110 80 0.100*
Building type
Permanent 108 82
Temporary 2 0 0.518*
Alcohol
Yes 5 5




Protected well 17 11
Table 1 Comparison of categorical socio-demographic
characteristics by H. pylori status (Continued)
Unprotected well 0 1





Medium (Secondary level) 72 52
High (tertiary education) 16 10 0.114*
Household monthly
income ($)
Low income (<100) 56 38
Medium income (101–250) 46 41
High income (>250) 8 3 0.374*
*P valve for the Pearson chi-square for the difference between H. pylori positive
and H. pylori negative; n is number, aone still birth was not weighed
Table 2 Comparison of continuous socio-demographic
characteristics by H. pylori status





Maternal age (years) 21.1 20.8 0.481**




Mean maternal height (cm) 157.5 157.2 0.727**
**P valve for the independent sample t test and n is number
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gestation weight gain rates <0.3 kg/week during the 2nd
and 3rd trimesters (OR 3.8, 95 % CI 1.0–14.1; P = 0.044)
(Table 5).
Discussion
The prevalence of H. pylori infection on the basis of
presence of H. pylori stool antigens in this population of
primigravidae and secundigravidae was 52.9 %. This is
within the range expected considering our country’s so-
cioeconomic level and prevalence of the infection among
pregnant women attending antenatal care clinic in the
same health centre in Kampala [2, 6]. The high rate of
H. pylori infection in this study mirrors the observation
of 69.8 %, 68.5 % and 52.2 % rate of H. pylori infection
among pregnant women in neighboring Sudan, Chile
and rural Mexico respectively [7–9]. Higher prevalence,
74 % and 88 %, of H. pylori infection was reported
among pregnant women at the US–Mexico border and
Egypt respectively [26, 27]. Our study comprised on
primigravidae and secundigravidae with the a mean ± SD
age of 20.9 ± 2.7 years and there is evidence that preva-
lence of H. pylori infection increase with increasing age
and number of deliveries [9].
Infants born from H. pylori positive women had a sig-
nificantly lower mean ± SD birth weight (2681 ± 370 g)
than those born from H. pylori negative women (3245 ±
407 g) P < 0.001. This perfectly agrees with the findings
of the study done in Turkey by Mulayim et al. [16].
Similarly infants born to primigravidae had a signifi-
cantly lower mean ± SD birth weight (2791 ± 422 g) than
those born to secundigravidae (3210 ± 465 g) P < 0.001.
This finding is in agreement with the findings of Chiba et
al. [28]. However, there were no differences in the LBW
prevalence between infants born to primigravidae and those
born to secundigravidae (P = 0.70). This finding is in con-
trast with the findings of Chiba and his colleagues who
found out that the LBW rate was significantly higher in
primigravidae than in multigravidae females. This difference
could be because our study population was homogenous in
most of the socio-demographic and nutritional characteris-
tics to detect significant association.
The prevalence of LBW in this study population was
13.6 % and this was slightly higher than the National LBW
prevalence (10.5 %) but mirrors the 14 % which has been
reported in parts of central Uganda where this study was
conducted [24]. We believe LBW in this urban population
was higher because of the nature of the population we
studied. In the present study, only those women pregnant
for the 1st or 2nd time with mean ± SD age was 20.9 ±
2.7 years were included while women of urban and rural
communities irrespective of gravidae and age were studied
in the National survey [24]. A good number of our partici-
pants (38.5 %) were pregnant for the 2nd time with mean ±
SD age of 21.7 ± 3.2 years. There is a body of evidence
which show that first born and second born babies born to
adolescents have higher chances of being born LBW [29].
There is also current evidence that age <20 years increases
the risk of giving birth to LBW baby [30].
In this study we found H. pylori infection to be an inde-
pendent predictor of low birth weight (OR = 3.6, 95 % CI:
1.1 – 11.5; P = 0.031). Our finding is in agreement with the
finding of Eslick et al. and Mulayim et al. [14, 16]. Eslick et
al. (2002) observed for the first time association between
H. pylori infection and low birth weight, in particular they
Table 3 Mean ± SD values selected variables in relation to H. pylori infection status
Variable Mean ± SD by H. Pylori Status Range P valve
H. pylori -ve (n = 82) H. pylori + ve (n = 110)
Rate of weight gain (kg/week) 0.33 ± 0.11 0.26 ± 0.10 0.08–0.75 <0.001
Gestational age (weeks) 39.4 ± 1.1 39.3 ± 1.0 37.0–42.0 0.494
Birth weight (g) 3245 ± 407 2681 ± 370 1700–4400 <0.001
Pre-pregnancy BMI (kg/m2) 21.2 ± 2.5 21.6 ± 2.9 15.0–29.4 0.35
Pre-pregnancy weight (kg) 52.6 ± 7.0 53.5 ± 8.1 37–76 0.392
Maternal height (cm) 157.3 ± 5.9 157.5 ± 5.9 142.0–173.1 0.727






Maternal rate of weight gain <0.3 kg/week 5.1 0.011 (1.5, 17.5)
Maternal height <156 cm 3.0 0.012 (1.3, 6.8)
Primigravidae 1.4 0.048 (1.1, 3.4)
H. pylori infection 4.9 0.005 (1.6, 14.8)





H. pylori infection 3.6 0.031 (1.1, 11.5)
Maternal rate of weight gain <0.3 kg/week 3.8 0.044 (1.0, 14.1)
Maternal height <156 cm 3.4 0.008 (1.4, 8.2)
Primigravidae 1.08 0.895 (0.34, 3.4)
Variables entered on step 1: H. pylori infection, maternal rate of weight gain,
maternal height, and parity
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showed that intrauterine growth restriction was more
common in H. pylori positive women (13.5 %) than in
negative mothers (6.0 %) (OR = 2.41; 95 % CI: 1.14–5.08;
P = 0.018). Mulayim et al. observed that pregnant women
with H. pylori infection delivered neonates with a signifi-
cantly lower birth-weight compared to mothers without
the infection. Furthermore, in animal models, it has been
reported that H. pylori infected mice showed a decrease in
implantation rates, and their offspring were of low birth
weight [31]. However, in another experimental mice model
study these results were not confirmed [32]. The mecha-
nism(s) by which H. pylori infection causes fetal growth re-
tardation is/are not very clear but several have been
suggested. H. pylori has been linked with an increase in
symptoms including dyspepsia, nausea or vomiting [8], be-
cause of underlying undiagnosed peptic ulcer disease,
which in turn may affect maternal gastric absorption and
therefore impair fetal growth. In humans, H. pylori infec-
tion has also been associated with anemia [33] and mater-
nal anemia associated to H. pylori infection may lead to
fetal growth restriction. In the study by Jasem et al., [33],
fetal growth retardation could have been due to maternal
anemia since all anemic pregnant women were in the H.
pylori positive group. Fetal growth retardation may be due
to either maternal or feto-placental causes. Feto-placental
causes include infections and other placental pathologies
[34]. It has been demonstrated that anti-CagA antibodies
cross-react in vitro with placental tissue reducing its inva-
siveness ability [35] and the consequent abnormal placen-
tation could lead to fetal growth restriction [34]. However,
Cardaropoli et al. found a strong association between H.
pylori infection and fetal growth retardation in preeclamp-
tic pregnancies, while there was no association between H.
pylori and idiopathic fetal growth retardation [12].
The pattern of maternal weight gain during pregnancy
is an important determinant of fetal growth [17]. This
study found out that primigravidae had a higher mean ±
SD rate of weight gain (0.33 ± 0.11 kg/week) than secun-
digravidae (0.27 ± 0.10 kg/week) P < 0.001. This finding
is in agreement with recent findings of Lumbanrajaa et
al., [36]. This present study also found rates of gestation
weight gain rates <0.30 kg/week during the 2nd and 3rd
trimesters to be an independent predictor of low birth
weight (OR = 3.8, 95 % CI 1.0–14.1; P = 0.044). This find-
ing of ours agrees with several other studies which have
reported that birth weight has positive correlations with
maternal gestation weight [37–39].
There was no difference in mean ± SD maternal height
between H. pylori positive (157.54 ± 5.92 cm) and H. pyl-
ori negative (157.25 ± 5.92 cm) (P = 0.73). However, ma-
ternal height less than 156 cm was another important
parameter which independently increased the risk for
LBW (OR = 3.4, 95 % CI 1.4–8.2; P = 0.008). Our cut off
point of 156 cm agrees well with other investigators in
Sudan, Brazil and Bangladesh who also found that ma-
ternal height below 156 cm increases the risk for LBW
and child mortality [30, 40, 41]. Elshibly et al. [41] found
maternal height <156 cm to increase LBW (AUC 0.591,
95 % CI 0.560–0.622; P = 0.003). This confirms the value
of maternal height as a predictor of childhood morbidity
and mortality.
The strength of our study lies in the fact it was a
prospective cohort and we were able to control some of
the known risk factors for LBW such as preterm de-
livery, chronic and genetic diseases. We also included a
homogenous population and we are able to attribute the
birth weights to H. pylori infection. We also included only
children delivered after 37 weeks of gestation so premature
babies were not part of our cohort. However, this current
study had some limitations. We did not collect data of all
the risk factors for LBW, for example, anemia, level of
physical activity during pregnancy, number of antenatal
visits, previous poor pregnancy outcome for secundigravi-
dae and complications which occurred during pregnancy
and labor neither did we consider other infections, such as
malaria and helmith, which are endemic in the area and
were previously reported as a cause of low LBW [42, 43].
Conclusion
In conclusion, the most important finding of this study
was that H. pylori infected pregnant women showed a sig-
nificantly a higher risk of giving birth to LBW babies. In
addition, primigravidae and secundigravidae with less a
height less than 156 cm had a higher risk of giving birth
to LBW babies. Irrespective of Maternal H. pylori infec-
tion status, maternal height and gestation rates of weight
gain remained the most important factors for LBW.
Recommendations
We recommend H. pylori infection screening for women
of child bearing age. Those found positive for H. pylori
infection should be treated before they get pregnant
since the available drug regimes for treatment of H. pyl-
ori are not safe in pregnancy. Pregnant women should
also be routinely counseled and monitored for gestation
weight gain to ensure adequate weight which results into
a normal birth weight baby.
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